The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Astellas Pharma; Astellas Pharma; AstraZeneca
Patents, Royalties, Other Intellectual Property - Co-author of the patent: "Advanced Multi Features Classification System for Skin Lesions Discrimination" STMicroelectronics Co- author of the patent: "Deep Learning Motion Algorithm for Lung Cancer Early Detection in Embedded Systems" STMicroelectronics
Travel, Accommodations, Expenses - Janssen Oncology
Final results from SAUL, a single-arm international real-world study of atezolizumab (atezo) in 1004 patients (pts) with pretreated locally advanced/metastatic urinary tract carcinoma (UTC).
 
Cora N. Sternberg
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Foundation Medicine; Genzyme; Gilead Sciences; Immunomedics; IMPAC Medical Systems; Incyte; Janssen Oncology; Janssen Oncology; Medscape; Merck; MSD; Pfizer; Roche; UroToday
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Immunomedics; Janssen; Janssen (Inst); Loxo/Lilly; MSD Oncology; MSD Oncology (Inst); Pfizer/EMD Serono; Roche; Seagen; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Basilea (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Ernest Choy
Honoraria - Abbvie; Amgen; Biogen; Chugai Pharma; Fresenius Kabi; Gilead Sciences; GlaxoSmithKline; Janssen; Lilly O.; R-Pharm; Sanofi; UCB
Consulting or Advisory Role - Abbvie; Amgen; Biogen; Chugai Pharma; Fresenius Kabi; Gilead Sciences; GlaxoSmithKline; Janssen; Lilly O.; R-Pharm; Sanofi; UCB
Speakers' Bureau - Abbvie; Amgen; Chugai Pharma; Fresenius Kabi; Galapagos NV; Lilly O.; Novartis; Pfizer; Sanofi
Research Funding - Bio-Cancer (Inst); Biogen (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen; UCB
 
Daniel Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Pfizer; Roche
 
Fernando Lopez-Rios Moreno
Honoraria - AstraZeneca; Bayer; BMS; Janssen; Lilly; MSD; Pfizer; Roche; Takeda; Thermo Fisher Scientific
Research Funding - Lilly; Roche; Thermo Fisher Scientific
 
Giuseppe Luigi Banna
No Relationships to Disclose
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck KGaA; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Cristina Masini
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; MSD
 
Aristotelis Bamias
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Debiopharm Group; MSD; Sanofi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ferring; Ipsen; MSD; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Pfizer (Inst); Roche (Inst)
 
Xavier Garcia del Muro
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EUSA Pharma; GlaxoSmithKline; Ipsen; Lilly; Merck; Pfizer; PharmaMar; Roche
Speakers' Bureau - Astellas Pharma; Eisai; Pfizer
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Pfizer; Roche
 
Ignacio Duran
Honoraria - Astellas Pharma; Bayer/Onyx; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Immunomedics; Janssen Oncology; MSD Oncology; Novartis; Pfizer/EMD Serono; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Bayer; Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca Spain; Ipsen; Pfizer/EMD Serono; Roche/Genentech
 
Thomas Powles
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Exelixis; Exelixis; Gilead Sciences; Incyte; Ipsen; Johnson & Johnson/Janssen; MashupMD; MashupMD; Merck; Merck Serono; Merck Serono; Merck Sharp & Dohme LLC; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; MashupMD; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche
 
Marija Gamulin
Consulting or Advisory Role - BMSi; Janssen Oncology; Pfizer/Astellas; Roche
Patents, Royalties, Other Intellectual Property - Janssen - drug donation for patients.
Travel, Accommodations, Expenses - Roche
 
Friedemann Zengerling
Honoraria - Astellas Pharma; Bayer/Vital; Ipsen; Janssen; Merck; Pfizer
Consulting or Advisory Role - Apogepha; AstraZeneca; Bayer Health; Bristol-Myers Squibb; IPSEN; Janssen; Merck; Merck Sharp & Dohme; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; IPSEN; Janssen; Pfizer
 
Lajos Geczi
No Relationships to Disclose
 
Craig Gedye
Consulting or Advisory Role - BCAL Diagnostics; Bristol-Myers Squibb (Inst); CADEX Genomics; Merck Sharp & Dohme (Inst); Novotech
Speakers' Bureau - Limbic Oncology (Inst)
 
Robert A Huddart
Leadership - Cancer clinic london Limited liability partnership
Consulting or Advisory Role - Bayer; Gilead Sciences; Janssen Oncology; Merck Sharp & Dohme; Nektar; Roche
Speakers' Bureau - Bristol Myers Squibb Foundation; Pfizer
Research Funding - Astellas Pharma (Inst); Basilea (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for dug discovery from Janssen (Inst)
Travel, Accommodations, Expenses - Nektar; Roche/Genentech
 
Geetha Kandula
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Pari Skamnioti
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Axel S. Merseburger
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen-Cilag; MSD Oncology; Takeda
Speakers' Bureau - Ipsen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen-Cilag (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen-Cilag